DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Microangiopathy
Microangiopathy
A Cross Sectional Study of Cutaneous Manifestations in 300 Patients of Diabetes Mellitus
Note for Guidance on Clinical Investigation of Medicinal Products for the Treatment of Peripheral Arterial Occlusive Disease
IWGDF Guideline on Diagnosis, Prognosis and Management of Peripheral Artery Disease in Patients with a Foot Ulcer and Diabetes
Coronary Microvascular Dysfunction
Origin of the Microangiopathic Changes in Diabetes
A Case of Malignant Hypertension-Induced Thrombotic Microangiopathy with Gradually Improved Renal Function Using Appropriate Antihypertensives
Cutaneous Collagenous Vasculopathy: Papular Form
Hypertensive Emergencies: an Update Paul E
University of Chicago, November 2004
Skin Manifestations in COVID-19: Prevalence and Relationship with Disease Severity
Current Management and Therapeutic Strategies for Cerebral Amyloid Angiopathy
The Syndromes of Thrombotic Microangiopathy: a Critical Appraisal on Complement Dysregulation
Thrombotic Microangiopathy As a Cause of Cardiovascular Toxicity from the BCR-ABL1 Tyrosine Kinase Inhibitor Ponatinib
A Rare Case of Cutaneous Collagenous Vasculopathy
Mimickers of Vasculitis
Malignant Hypertension with Thrombotic Microangiopathy
Comparative Study of Campbell De Morgan Spots in the Diabetics and the Non- Diabetics
Poor Metabolic Control, Hypertension and Microangiopathy Independently Increase the Transcapillary Escape Rate of Albumin in Diabetes
Top View
View Presentation
The Relationship Between Microalbuminuria And
Thrombotic Microangiopathy and Venous Thrombosis in a Patient with Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Case Report Thrombotic Microangiopathy with ANCA-Associated Vasculitis in a Child: a Case Report and Review of Literature
Progressive Widespread Telangiectasias
Patient - Hemlibra and Thrombotic Microangiopathy and Blood Clot (Thrombotic Event) Side Effects
Malignant Hypertension-Associated Thrombotic Microangiopathy Following Cocaine Use
Isolated Renal Thrombotic Microangiopathy As an Initial Presentation of Scleroderma Without Other Systemic Manifestations of the Disease
Thrombotic Microangiopathy in Malignant Hypertension
Chronic Kidney Disease Induces a Systemic Microangiopathy, Tissue
A Case Report of Thrombotic Microangiopathic Malignant
Peripheral Artery Disease Go-To Guide
Coronary Microangiopathy in Type 2 Diabetic Patients: Relation to Glycemic Control, Sex, and Microvascular Angina Rather Than to Coronary Artery Disease
Diagnostic Value of Hemostatic Parameters in Bone Marrow Transplant- Associated Thrombotic Microangiopathy
Renal Hemosiderosis with Bevacizumab Induced Thrombotic Microangiopathy in a Patient with Hereditary Hemorrhagic Telangiectasia
Differences and Similarities Between Disseminated Intravascular
The Relationship Between Nailfold Capillaroscopic Assessment and Telangiectasia Score with Severity of Peripheral Vascular Involvement in Systemic Sclerosis Y
Microvascular and Macrovascular Disease and Risk for Major Peripheral Arterial Disease in Patients with Type 2 Diabetes
View and Update
Angiokeratoma: Decisionmaking Aid for the Diagnosis of Fabry Disease
Vasculopathy and Vasculitis
A Case of Recurrent Thrombotic Microangiopathy Caused by Hypertensive Urgency
Complement-Mediated Microangiopathy in Iga Nephropathy and Iga Vasculitis with Nephritis
Peripheral Artery Disease: Epidemiology and Global Perspectives
Revista ABD Volume 92 Numero 4
Jemds.Com Original Research Article
Influence of Micro- and Macro-Vascular Disease and Tumor Necrosis Factor Receptor 1 on the Level of Lower-Extremity Amputation I
Thrombotic Microangiopathy Among Hospitalized Patients with Systemic Lupus Erythematosus in the United States
Cutaneous Collagenous Vasculopathy
Differentiating TTP from Hypertensive Hemolytic Anemia Chelsea Dixon-Dionne Henry Ford Health System